In the last 12 months, insiders at CytoDyn Inc. ($CYDY) filed 39 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
CytoDyn Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Hoffman Robert E. (Chief Financial Officer) — 2 transactions totaling $0
- Urbach Tanya Durkee (Director) — 3 transactions totaling $0
- Blok Tyler (EVP of Legal Affairs) — 3 transactions totaling $0
- Ndhlovu Lishomwa C (Director) — 3 transactions totaling $0
- SIMES STEPHEN M (Director) — 3 transactions totaling $0
View all SEC Filings for CytoDyn Inc. (CYDY).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | Blok Tyler | Chief Legal Officer | A | Non-qualified stock option (right to buy) | 3249794 | $0.00 | 3,249,794.0000 | 1,261,016,000 | 9999.99% | 0.26% |
| March 20, 2026 | Dunlap Ryan | Director | A | Non-qualified stock option (right to buy) | 574385 | $0.00 | 574,385.0000 | 1,261,016,000 | 9999.99% | 0.05% |
| March 20, 2026 | Hoffman Robert E. | Chief Financial Officer | A | Non-qualified stock option (right to buy) | 4874691 | $0.00 | 4,874,691.0000 | 1,261,016,000 | 9999.99% | 0.39% |
| March 20, 2026 | Lalezari Jacob P | Chief Executive Officer | A | Non-qualified stock option (right to buy) | 4874691 | $0.00 | 4,874,691.0000 | 1,261,016,000 | 9999.99% | 0.39% |
| March 20, 2026 | Ndhlovu Lishomwa C | Director | A | Non-qualified stock option (right to buy) | 574385 | $0.00 | 574,385.0000 | 1,261,016,000 | 9999.99% | 0.05% |
| March 20, 2026 | SIMES STEPHEN M | Director | A | Non-qualified stock option (right to buy) | 574385 | $0.00 | 574,385.0000 | 1,261,016,000 | 9999.99% | 0.05% |
| March 20, 2026 | Urbach Tanya Durkee | Director | A | Non-qualified stock option (right to buy) | 574385 | $0.00 | 574,385.0000 | 1,261,016,000 | 9999.99% | 0.05% |
| March 20, 2026 | Brunke Karen J | Director | A | Non-qualified stock option (right to buy) | 574385 | $0.00 | 574,385.0000 | 1,261,016,000 | 9999.99% | 0.05% |
| May 15, 2025 | Hoffman Robert E. | Chief Financial Officer | A | Non-qualified stock option (right to buy) | 1000000 | $0.00 | 1,000,000.0000 | 1,228,259,000 | 9999.99% | 0.08% |
| Oct. 28, 2024 | Ndhlovu Lishomwa C | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 1,198,287,000 | 9999.99% | 0.07% |
| Oct. 28, 2024 | Urbach Tanya Durkee | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 1,198,287,000 | 9999.99% | 0.07% |
| Oct. 28, 2024 | SIMES STEPHEN M | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 1,198,287,000 | 9999.99% | 0.07% |
| Oct. 28, 2024 | Lalezari Jacob P | Chief Executive Officer | A | Non-qualified stock option (right to buy) | 3000000 | $0.00 | 3,000,000.0000 | 1,198,287,000 | 9999.99% | 0.25% |
| Oct. 28, 2024 | Dunlap Ryan | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 1,198,287,000 | 9999.99% | 0.07% |
| Oct. 28, 2024 | Brunke Karen J | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 1,198,287,000 | 9999.99% | 0.07% |
| Oct. 28, 2024 | Blok Tyler | Chief Legal Officer | A | Non-qualified stock option (right to buy) | 1250000 | $0.00 | 1,250,000.0000 | 1,198,287,000 | 9999.99% | 0.10% |
| March 7, 2024 | Lalezari Jacob P | Chief Executive Officer | A | Non-qualified stock option (right to buy) | 3000000 | $0.00 | 3,000,000.0000 | 982,209,000 | 9999.99% | 0.31% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | A | Non-qualified stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 958,988,000 | 9999.99% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | A | Non-qualified stock option (right to buy) | 50000 | $0.00 | 50,000.0000 | 958,988,000 | 9999.99% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | A | Non-qualified stock option (right to buy) | 1000000 | $0.00 | 1,000,000.0000 | 958,988,000 | 9999.99% | 0.10% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | A | Non-qualified stock option (right to buy) | 630222 | $0.00 | 630,222.0000 | 958,988,000 | 9999.99% | 0.07% |
| Jan. 3, 2024 | Urbach Tanya Durkee | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 958,988,000 | 9999.99% | 0.08% |
| Jan. 3, 2024 | SIMES STEPHEN M | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 958,988,000 | 9999.99% | 0.08% |
| Jan. 3, 2024 | Ndhlovu Lishomwa C | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 958,988,000 | 9999.99% | 0.08% |
| Jan. 3, 2024 | Dunlap Ryan | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 958,988,000 | 9999.99% | 0.08% |
| Jan. 3, 2024 | Brunke Karen J | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 958,988,000 | 9999.99% | 0.08% |
| Jan. 3, 2024 | Blok Tyler | EVP of Legal Affairs | D | Non-qualified stock option (right to buy) | 100000 | $0.00 | 0.0000 | 958,988,000 | 100.00% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | A | Non-qualified stock option (right to buy) | 50000 | $0.00 | 50,000.0000 | 958,988,000 | 9999.99% | 0.01% |
| Jan. 3, 2024 | Blok Tyler | EVP of Legal Affairs | A | Non-qualified stock option (right to buy) | 1000000 | $0.00 | 1,000,000.0000 | 958,988,000 | 9999.99% | 0.10% |
| Jan. 3, 2024 | Blok Tyler | EVP of Legal Affairs | A | Non-qualified stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 958,988,000 | 9999.99% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | D | Non-qualified stock option (right to buy) | 50000 | $0.00 | 0.0000 | 958,988,000 | 100.00% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | D | Non-qualified stock option (right to buy) | 50000 | $0.00 | 0.0000 | 958,988,000 | 100.00% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | A | Non-qualified stock option (right to buy) | 50000 | $0.00 | 50,000.0000 | 958,988,000 | 9999.99% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | D | Non-qualified stock option (right to buy) | 630222 | $0.00 | 0.0000 | 958,988,000 | 100.00% | 0.07% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | D | Non-qualified stock option (right to buy) | 1000000 | $0.00 | 0.0000 | 958,988,000 | 100.00% | 0.10% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | D | Non-qualified stock option (right to buy) | 50000 | $0.00 | 0.0000 | 958,988,000 | 100.00% | 0.01% |
| Jan. 3, 2024 | Migliarese Antonio | CFO | D | Non-qualified stock option (right to buy) | 100000 | $0.00 | 0.0000 | 958,988,000 | 100.00% | 0.01% |
| Feb. 13, 2023 | Arman Arvin Cyrus | President | A | Warrants (right to buy) | 434782 | $0.00 | 434,782.0000 | 813,373,000 | 9999.99% | 0.05% |
| Feb. 13, 2023 | Arman Arvin Cyrus | President | A | Common Stock | 434782 | $0.00 | 1,081,334.0000 | 813,373,000 | 67.25% | 0.05% |